Anpario (LON:ANP - Get Free Report) had its price objective hoisted by analysts at Canaccord Genuity Group from GBX 380 ($4.64) to GBX 500 ($6.10) in a report issued on Tuesday, MarketBeat.com reports. The firm presently has a "buy" rating on the stock. Canaccord Genuity Group's price objective points to a potential upside of 11.19% from the company's previous close.
Separately, Canaccord Genuity Group increased their price target on Anpario from GBX 340 ($4.15) to GBX 370 ($4.52) and gave the company a "buy" rating in a research note on Wednesday, September 18th.
Get Our Latest Stock Report on Anpario
Anpario Trading Up 4.0 %
Shares of ANP traded up GBX 17.20 ($0.21) on Tuesday, reaching GBX 449.70 ($5.49). 98,230 shares of the company's stock were exchanged, compared to its average volume of 54,069. Anpario has a 12 month low of GBX 220 ($2.69) and a 12 month high of GBX 452 ($5.52). The stock has a market capitalization of £76.04 million, a P/E ratio of 2,498.33 and a beta of 0.58. The company has a current ratio of 6.15, a quick ratio of 5.16 and a debt-to-equity ratio of 0.21. The business has a 50 day moving average price of GBX 359.86 and a two-hundred day moving average price of GBX 321.21.
Insider Buying and Selling at Anpario
In related news, insider Karen Prior sold 14,000 shares of the business's stock in a transaction that occurred on Friday, December 13th. The stock was sold at an average price of GBX 380 ($4.64), for a total value of £53,200 ($64,949.33). Insiders own 30.51% of the company's stock.
Anpario Company Profile
(
Get Free Report)
Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.
Featured Articles
Before you consider Anpario, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anpario wasn't on the list.
While Anpario currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.